CA2192849C - Dna molecules which code for a plastid 2-oxoglutarate/malate translocator - Google Patents

Dna molecules which code for a plastid 2-oxoglutarate/malate translocator Download PDF

Info

Publication number
CA2192849C
CA2192849C CA002192849A CA2192849A CA2192849C CA 2192849 C CA2192849 C CA 2192849C CA 002192849 A CA002192849 A CA 002192849A CA 2192849 A CA2192849 A CA 2192849A CA 2192849 C CA2192849 C CA 2192849C
Authority
CA
Canada
Prior art keywords
leu
oxoglutarate
dna molecule
ala
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002192849A
Other languages
French (fr)
Other versions
CA2192849A1 (en
Inventor
Ulf-Ingo Flugge
Andreas Weber
Karsten Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Michigan State University MSU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michigan State University MSU filed Critical Michigan State University MSU
Publication of CA2192849A1 publication Critical patent/CA2192849A1/en
Application granted granted Critical
Publication of CA2192849C publication Critical patent/CA2192849C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8251Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology

Abstract

DNA molecules are described which code for a plastid 2-oxoglutarate/malate translocator, particularly from Spinacia oleracea, as well as bacteria, fungi, transgenic plant cells and transgenic plants containing such DNA molecules.

Description

DNA molecules which code for a plastid 2-oxoglutarate/malate translocator The present invention relates to DNA molecules, particularly from Spinacia oleracea, containing the coding region of a 2-oxoglutarate/malate transporter and the introduction of which into a plant genome modifies the production and transport of carbon skeletons for nitrogen fixation and the transport of the assimilated nitrogen in transgenic plants.
The invention furthermore relates to plasmids, yeasts and bacteria containing said DNA molecules, as well as to transgenic plants in which modifications of the activity of the 2-oxoglutarate/malate transporter and thus modifications of the nitrogen and carbon metabolism are brought about by introduction of said DNA molecules. The invention furthermore relates to transgenic plants the photo-respiratory capability of which is influenced by the modification of the activity of the 2-oxoglutarate/malate transporter. The invention also relates to the use of the DNA molecules described which code for a 2-oxoglutarate/malate translocator for the identification of related translocators from Spinacia oleracea and other plants by low-stringency hybridization or by PCR techniques, as well as the use of the 2-oxoglutarate/malate translocator as target for herbicides.

Only plants, bacteria and yeasts are capable of converting on a large scale inorganic nitrogen (nitrate nitrogen) into organically fixed nitrogen (usually in the form of amino acids) by reductively aminating organic carbon compounds.
The remainder of the animated world, particularly useful animals and humans, is dependent on plants as primary suppliers of organic nitrogen compounds. Assimilation of inorganic nitrogen in plants by fixation to organic carbon depends on the availability of nitrogen, carbon skeletons and energy.
The nitrogen supply of the plant can be influenced by fertilizers. The energy for nitrogen assimilation is derived from the light reaction of photosynthesis or in roots or other non-green tissues from dissimilation and under normal field conditions is no limiting factor.

2-oxoglutarate (a-ketoglutarate) according to today's knowledge is the primary acceptor of reduced nitrogen in the glutamine synthase/glutamine 2-oxoglutarate aminotransferase (GOGAT) reaction. In this reaction nitrogen (ammonium nitrogen) reduced by glutamine synthase is first transferred onto glutamate under energy consumption. Glutamine is formed. In a sequential reaction the glutamate oxoglutarate aminotransf erase (GOGAT; glutamate synthase) catalyzes the transfer of an amino group of glutamine onto 2-oxoglutarate (transamination) while consuming reduction equivalents. Two glutamate molecules are formed.

The entire reaction sequence of the glutamine synthase/GOGAT
reaction is localized in the stroma of the plant plastids.
These organelles are surrounded by two lipid bilayer membranes, with the exterior having molecular sieve character and being permeable to compounds up to a size of about 10 kD (Fliigge and Benz, 1984, FEBS Lett. 169:85-89).
The inner membrane is permeable to some smaller compounds such as water, carbon dioxide, oxygen and nitrite, however, not to larger charged molecules such as 2-oxoglutarate.
The key compound of the glutamine synthase/GOGAT reaction, the 2-oxoglutarate, must be moved from the cytosol of the plant cell by a specific translocator across the inner membrane of the chloroplast envelope into the stroma of the plastid. Transport of 2-oxoglutarate into the plastids takes place in exchange with malate from the plastids via the 2-oxoglutarate/malate translocator. The malate exported in this process into the cytosol is transported back by a ?192849 second translocator, the dicarboxylate translocator, which is related with the 2-oxoglutarate/malate translocator in its substrate specificity, in exchange with glutamate. As a result, 2-oxoglutarate is imported into the chioroplast and the end product of the glutamine synthase/GOGAT reaction, glutamate, is exported without a net transport of malate which circulates via both translocator systems ("double translocator", Woo et al., 1987, Plant Physiol. 84:624-632;
Flugge et al., 1988, Planta 174:534-541). Glutamate is the plant's preferred amino group donor in a series of transaminat-ion reactions, for example in the biosynthesis of the amino acids alanine or phenylalanine, etc. Furthermore, glutamate is an important transport form for organically bound nitrogen within the plant. Most nitrogen-containing compounds in the plant such as amino acids, nucleic acids or alkaloids require glutamate as primary amino acid donor for their biosynthesis pathway.

The 2-oxoglutarate required for nitrogen assimilation is essentially synthesized by conversion of citrate in the cytoplasm of the cells.
More recent publications (Riesmeier et al., 1993, Proc.
Natl. Acad. Sci. USA 90:6160-6164; Heineke et al., 1994, Planta 193:174-180) show that the effectivity of the photosynthetic carbon reaction is inter alia substantially limited by the export of the reduced, organically bound carbon (triose phosphate) formed which is catalyzed by a translocator localized in the inner membrane of the chloroplast envelope. This translocator protein thus is a "bottle-neck" in the carbon metabolism. The plastid 2-oxoglutarate/malate translocator plays a similar role in the nitrogen metabolism.

The plastid 2 -oxoglutarate/ma late translocator thus plays a key role in the nitrogen metabolism of plants since it is responsible for supplying sufficient amounts of the substrate for nitrogen assimilation by the glutamine 4 2i7Z04-9 synthase/GOGAT reaction. By manipulating the activity of this translocator it would therefore presumably be possible to influence the effectivity of nitrogen assimilation in plants.

Since the majority of humans on earth has to depend on a vegetarian diet, resulting in a continuous inadequate provision with proteins in these social strata, there is an urgent demand for plants having an increased content in organic nitrogen compounds, particularly proteins and amino acids. In the industrialized countries animal and fish meal is increasingly being added to animal feeding stuff to improve the provision of breeding animals with proteins.
Forage plants having a higher protein content would surely be the better alternative in particular considering the problems, such as BSE, arising from the feeding of animal meals.

It would be possible to influence the activity of the plastid 2-oxoglutarate/malate translocator via genetic engineering techniques if DNA sequences coding for such a translator were available. So far, this has not been the case. The provision of DNA sequences coding for a 2-oxoglutarate/malate translocator would furthermore allow identification of substances which specifically inhibit said translocator and which can hence be used as herbicides.

Presently, sequences of translocator proteins of the substrate specificity described above are known only from the mitochondria of bovine hearts and from human mitochondria (Runswick et al., 1990, Biochemistry 29:11033-11040; Iacobazzi et al., 1992, DNA Seq. 3(2):79-88). These transporters play an essential role in the mitochondrial dicarboxylate metabolism (inter alia malate/aspartate shuttle, oxoglutarate/isocitrate shuttle) and pertain to the family of mitochondrial metabolite transporters which are closely interrelated. For example, the mitochondrial carriers (phosphate/OH-, ADP/ATP, oxoglutarate/malate, etc.) are characterized by sequence relationship and by the presence of internal repeats. Furthermore, it could be shown for the most mitochondrial carriers as for the 2-oxoglutarate carrier that they are incorporated into the mitochondrial membrane without a presequence (targeting sequence) directing them to the organelles (Runswick et al., 1990, Biochemistry 29:11033-11040). It can thus be presumed that the targeting information is contained in the mature carrier protein. An over-expression of a mitochondrial dicarboxylate transporter in plants would thus not result in an increase in the oxoglutarate transport across the plastid envelope membrane but only in an increase in the mitochondrial dicarboxylate transport, which is an undesired effect.

In contrast to the above, the proteins of the inner envelope membrane of the plastid require a presequence specifically directing them to the plastids (overview articles: Keegstra et al., 1989, Annu. Rev. Plant. Physiol. Plant Mol. Biol.
40:471-501; Lubben et al., 1988, Photosynth. Res. 17:173-194; FlUgge, 1990, J. Cell Sci. 96:351-354). In addition to the presequence needed for "plastid targeting", there is further information in the mature part (the part of the protein remaining after cleavage of the presequence by a specific protease) of the plastid envelope membrane proteins which prevents transport of the envelope membrane proteins across the envelope membrane into the plastid stroma or the thylakoid membrane (own, unpublished observations; Li et al., 1992, J. Biol. Chem. 267:18999-19004). So far it has not been possible to exactly localize this information in the mature part of the proteins of the inner envelope membrane known so far (37 kD protein: Dreses-Werringloer et al., 1991, Eur. J. Biochem. 195:361-368; triose-phosphate/phosphate translocator: Fliigge et al., 1989, EMBO
J. 8:39-46; Willey et al., 1991, Planta 183:451-461; Fischer et al., 1994, Plant Jour. 5(2):215-226; Ca2+ ATPase: Huang 6 2~92849 et al., 1993, Proc. Natl. Acad. Sci. USA 90:10066-10070).
Our own investigations conducted with a mitochondrial carrier, the ADP/ATP transporter, showed that this protein cannot or only very ineffectively be directed to the chloroplasts and there be incorporated in the envelope membrane. Even a hybrid protein, consisting of a chloroplastid presequence (containing the information for chloroplast targeting) and said mitochondrial carrier showed only a slight increase in incorporation into the chloroplast envelope membrane as compared to the authentic protein (unpublished observations). Since the protein/lipid interaction is important for a correct insertion and the chloroplastid envelope membrane fundamentally differs in its lipid composition from that of the mitochondria (Joyard et al., 1991, Eur. J. Biochem. 199:489-509), it is highly improbable that an insertion of a mitochondrial protein, albeit a minor one, will be functional, i.e., that a transporter from other organelles can be incorporated at all into the chloroplast envelope membrane in a conformation and orientation corresponding to its function.

Thus, according to the present state of the art, it is not possible to functionally integrate, e.g., mitochondrial or procaryotic dicarboxylate transporters into the inner envelope membrane of the chloroplasts by using known plastid targeting sequences. With the present state of the art it is more promising to achieve the DNA sequence required for the construction of the plants described above by cloning the authentic plastid 2-oxoglutarate/malate translocator.

This cloning, however, cannot be performed by low-stringency screening of a plant cDNA library with a probe derived from the mitrochondrial dicarboxylate transporters. According to what is known today, the chloroplastid translocators have a primary sequence that is completely different from all translocators from other systems (bacteria, mitochondria) -even if the protein has a comparable function. Therefore, 7 t~9 28 4' the route of biochemical characterization, purification and isolation of the 2-oxoglutarate/malate translocator had to be taken, which is extremely difficult in membrane proteins.
Identification of the translocator protein as component of the inner envelope membrane of the chloroplast having an apparent molecular weight of 45,000 Dalton was now possible (Menzlaff and FlUgge, 1993, Biochim. Biophys. Acta 1147:13-18). However, the purification procedure described is not suitable to produce sufficient amounts of protein for protein sequencing, since it turned out that the N terminus of the protein was blocked and thus was not available for N-terminal protein sequencing by automated Edman degradation.
Therefore, it has not been possible so far to isolate, starting from the amino acid sequence, DNA molecules coding for a plastid 2-oxoglutarate/malate translocator.

The problem underlying the present invention therefore is to provide processes and DNA molecules the use of which makes it possible to modify plants such that they are capable of synthesizing an increased amount of organic nitrogen compounds. Specifically, the problem underlying the invention is to provide DNA molecules coding for a plastid 2-oxoglutarate/malate translocator.

The problem is solved by the provision of the embodiments characterized in the patent claims.

The present invention therefore relates to DNA molecules coding for a plastid 2-oxoglutarate/malate translocator, with the information contained in the nucleotide sequence leading to the formation of a ribonucleic acid upon introduction and expression in plant cells and allowing introduction of a 2-oxoglutarate/malate translocator activity into the cells via this ribonucleic acid or suppressing an endogenous 2-oxoglutarate/malate translocator activity.

? ;9 2u4 The present invention particularly relates to DNA molecules coding for a protein having the amino acid sequence indicated in Seq ID No. 1, as well as DNA molecules comprising the coding region indicated in Seq ID No. 1. It furthermore relates to DNA molecules that hybridize to the aforementioned DNA molecules of the invention, and to DNA
molecules the sequence of which is degenerate as a result of the genetic code, with these latter molecules coding for a protein having 2-oxoglutarate/malate translocator activity.
Another subject matter of the invention are DNA molecules which are eomplementary to those mentioned above, as well as fragments and derivatives of the aforementioned DNA
molecules according to the invention, which can be derived by, e.g., insertion, substitution or deletion, and code for a 2-oxoglutarate/malate translocator.

The term "hybridization" in the present context is understood to mean hybridization under conventional conditions such as described in, e.g., Sambrook et al.
(1989, Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), preferably hybridization under stringent conditions (likewise described in Sambrook et al., supra).

The DNA molecules (or derivatives or parts of these molecules) of the present invention can be introduced into plasmids that allow a mutagenesis or a sequence modification by recombination of DNA sequences in procaryotic or eucaryotic systems, thereby allowing modification of the specificity of the 2-oxoglutarate/malate translocator. By modifying the specificity of the translocator in direction of improved specificity for glutamate and simultaneous reduced specificity for malate, the "double translocator"
system described above could be modified so as to achieve further improved transport rates for 2-oxoglutarate in direct exchange for glutamate. Also, an insensitivity to herbicides specific of the 2-oxoglutarate/malate translocator could be achieved. Standard techniques (Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, NY, USA) can be employed to bring about base exchanges and/or base deletions and/or to add synthetic or natural sequences.
For an interlinkage of the DNA fragments, adapters or linkers can be used. Furthermore, manipulations providing suitable restriction sites or deleting DNA not required can be used. Where insertions, deletions or substitutions such as transitions or transversions are feasible, in vitro mutagenesis-, primerrepair, restriction or ligation can be used. Methods lending themselves for analysis are generally sequence analysis, restriction analysis and other biochemical molecular biological methods such as the expression of the modified protein in fission yeast and measuring the modified transport properties in artificial liposomes (see Example 4 and Loddenkotter et al., 1993, Proc. Natl. Acad. Sci. USA 90:2155-2159; as well as Fischer et al., 1994, Plant Journal 5:215-226) or measuring the modified transport properties in the protein expressed in transgenic plants using a method which was only recently devised for this purpose by the inventors (FlUgge and Weber, 1994, Planta, 194:181-185).

The DNA molecules according to the invention (or parts or derivatives of these molecules) can be used to isolate from the genome of plants similar DNA molecules by standard techniques which likewise code for a 2-oxoglutarate/malate translocator or a similar dicarboxylate translocator.
Particularly useful methods are low-stringency hybridization screening of cDNA libraries using the DNA molecule according to the invention or parts thereof as probes or constructions of such probes for stringency and low-stringency screening strategies by deriving degenerate and/or non-degenerate primers from the sequences of the DNA molecules according to the invention for PCR experiments with DNA or cDNA of spinach or other plants. The DNA molecules can also be used 2~92849 to identify and isolate DNA molecules which code for the closely related glutamate-malate translocator (dicarboxylate translocator) of the plastid envelope membrane (subtractive screening methods of a cDNA library from spinach or other plants under varying stringency conditions and with various regions of the DNA molecules according to the invention as probe).

In another embodiment, the present invention relates to the use of the DNA molecules according to the invention or parts or derivatives thereof, derived from these DNA molecules by insertion, deletion or substitution, for the transformation of pro- and eucaryotic cells. In order to guarantee expression of the 2-oxoglutarate/malate translocator in transformed cells, the DNA molecules according to the invention can be introduced into vectors, preferably plasmids, and can be combined with control elements for the expression in procaryotic or eucaryotic cells (see Examples 3 and 5). Such control elements are transcription promoters or transcription terminators. The vectors can be used to transform eucaryotic cells with the purpose of expressing a translatable messenger ribonucleic acid (mRNA) which allows synthesis of a plastid 2-oxoglutarate/malate translocator in the transformed cells or with the purpose of expressing a non-translatable, inversely oriented (anti-sense) messenger ribonucleic acid which prevents synthesis of the endogenous 2-oxoglutarate/malate translocators. For this purpose, also shorter fragments of the DNA molecules according to the invention can be used or DNA molecules the sequence of which has a relatively high degree of homology (more than about 65% homology) to the sequences of the DNA molecules according to the invention. Likewise, expression of endogenous dicarboxylate translocators can be inhibited by the expression of a ribozyme constructed for this purpose and using the DNA molecules according to the invention.

11 2'9224~

In another embodiment, the present invention therefore relates to recombinant DNA molecules, for example plasmids, comprising one of the DNA molecules according to the invention, e.g., plasmids pBinAR-211 (DSM 9239), pEVP11-211 (DSM 9237) and pBSC-211 (DSM 9238).

The subject matter of the invention are particularly recombinant DNA molecules in which a DNA molecule according to the invention is linked with DNA sequences which allow expression in pro- or eucaryotic cells.

In another embodiment, the present invention relates to bacteria containing DNA molecules according to the invention or recombinant DNA molecules according to the invention.

The present invention furthermore relates to proteins having the activity of a 2-oxoglutarate/malate translocator which are coded for by the DNA sequence of one of the DNA
molecules according to the invention. Preferred proteins are those from dicotyledonous or monocotyledonous plants, particularly from plants of the family of Chenopodiaceae and particularly preferred from Spinacia oleracea.

The production of such proteins can be achieved in that, e.g., DNA molecules according to the invention which code for a 2-oxoglutarate/malate translocator are linked with DNA
sequences which ensure transcription in pro- or eucaryotic cells. The resulting recombinant molecules can then be introduced into and expressed in suitable pro- or eucaryotic host cells. The resulting protein can be isolated according to known methods. It is also possible to express a shortened protein which contains no signal sequences allowing localization of the protein in the inner envelope membrane of the plastids.

In another preferred embodiment, the present invention relates to the use of the DNA molecule according to the 12 ~ - 92849 invention for the expression of a 2-oxoglutarate/malate translocator in plant cells.

By expressing a RNA corresponding to the DNA molecules according to the invention coding for a plant 2-oxoglutarate/malate translocator it is possible to modify the plant nitrogen metabolism. The economic importance thereof is that an improvement of the transport of 2-oxoglutarate from the cytosol into the plastid results in a modification of the ratio of carbohydrates (sugar, starch, organic acids) and fats in favor of the nitrogen compounds (amino acids, proteins, possibly alkaloids). In this manner, plants can be generated that are richer in valuable protein but exhibit a reduced content of carbohydrates and fats.
This modification increases the nutritional value of plants and thus also their economic value.

Methods for the genetic modification of dicotyledonous and monocotyledonous plants are already known (Gasser and Fraley, 1989, Science 244:1293-1299; Potrykus, 1991, Ann.
Rev. Plant Mol. Biol. Plant Physiol. 42:205-225). For an expression of coding sequences in plant these have to be linked with transcriptional regulatory elements. Such elements, referred to as promoters, are known (inter alia Koster-Topfer et al., 1989, Mol. Gen. Genet. 219:390-396).
Furthermore, the coding regions have to be provided with the transcription termination signal for them to be correctly transcribed. Such elements were also already described (Gielen et al., 1989, EMBO J. 8, 23-29). The transcriptional start region can be both native or homologous and foreign or heterologous to the host plant. Termination regions are freely interchangeable. The DNA sequence of the transcription start and termination regions can be synthetically produced or obtained from natural sources or can contain a mixture of synthetic and natural DNA
components.

For the preparation of the introduction of foreign genes into higher plants there is a large number of cloning vectors available which contain a replication signal for E.
coli and a marker allowing selection of the transformed cells. Examples of vectors are pBR322, pUC series, M13mp series, pACYC 184 etc. Further DNA sequences may be necessary depending on the method of introduction of desired genes into plants. If, e.g., the Ti or Ri plasmid is used to transform the plant, at least the right border, often, however, the right and the left border of the Ti and Ri plasmid T-DNA must be added to the genes to be introduced as flanking region. The use of T-DNA for the transformation of plant cells has been thoroughly examined and sufficiently described (Hoekema in: The Binary Plant Vector System, Offsetdrukkerij Kanters B-V. Ablasserdam, 1985, Chapter V;
Fraley et al., Critic. Rev. Plant Sci. 4:1-46; An et al., 1985, EMBO J. 4:277-287). Once the introduced DNA is integrated into the genome it usually is stable there and is preserved in the progeny of the originally transformed cells. Normally, it contains a selection marker which imparts to the transformed plant cells a resistance to biocides or antibiotics such as kanamycin, bleomycin or hygromycin. The individually introduced maker will therefore allow selection of transformed cells vis-a-vis cells lacking the introduced DNA.

There are many techniques other than the transformation with agrobacteria to introduce DNA in a plant host cell. These techniques include the transformation of protoplasts, microinjection of DNA, electroporation as well as ballistic methods. Whole plants can then be regenerated from the transformed plant material in a suitable selection medium.
The plants obtained in this manner can be tested by conventional methods of molecular biology for the presence of the introduced DNA. These plants can be normally grown and cross-bred with plants possessing the same transformed hereditary information or a different hereditary ' ) 9Z849 information. The resulting hybrid individuals have the corresponding phenotypic properties.

Therefore, the present invention also relates to transgenic plant cells containing the recombinant DNA molecules according to the invention, as well as transgenic plants reproducible from these transgenic plant cells and transgenic plants containing plant cells according to the invention. These plant cells and plants are characterized in that they contain a recombinant DNA molecule integrated into the genome-which allows expression of a protein having the activity of a 2-oxoglutarate/malate translocator or the expression of a non-translatable RNA molecule inhibiting the synthesis of 2-oxoglutarate/malate translocators.
Furthermore, the present invention relates to seed of the transgenic plants according to the invention.

In another embodiment, the present invention relates to the heterologous expression of the DNA molecules according to the invention in fungi, e.g., in fission yeasts (Examples 3, 4 and Loddenkdtter et al., 1993, Proc. Natl. Acad. Sci. USA
90:2155-2159), particularly for structural-functional studies of the 2-oxoglutarate/malate translocator, which may lead to the development of a specific inhibitor for this protein. In this context also the development of herbicides is conceivable, since the inhibition of a protein having a key role in the metabolism would inevitably be lethal for the plant.

Therefore, the DNA molecules according to the invention (or parts of these molecules or derivatives of these molecules) can thus be introduced into vectors and can be provided with control elements for the expression in fungal cells, particularly in fission yeasts (see Example 3). The introduction of the 2-oxoglutarate/malate translocator results in a substantial increase in the activity of the 2-oxoglutarate/malate translocator in the recombinant yeast 15 ?192849 cells which activity can be measured by reconstitution in artificial liposomes. It should be noted in this context that mitochondria possess a 2-oxoglutarate/malate translocator which is similar in its substrate specificity to that of the plastids, which, however, is not similar to the plastid translocator as regards its DNA and amino acid sequence (Runswick et al., 1990, Biochemistry 29:11033-11040). In recombinant yeast cells an up to 100-fold higher malate transport activity is detectable. It is therefore conceivable to modify yeast cells such that they exhibit a modified protein content by using the DNA molecules according to the invention (or parts or derivatives of these molecules). For this purpose, the advantage of the plastid translocator from plants, namely that it is not subject to the endogenous regulatory and compartment targeting mechanisms of fission yeasts, would come in useful. It is highly probable that the described increase in malate transport activity in the yeast cells would not be possible by an expression of a mitochondrial 2-oxoglutarate translocator. These strains would be of utmost importance for the feeding stuff industry.

Thus, the invention also relates to fungal cells, particularly to yeast cells, containing a DNA molecule according to the invention or a recombinant DNA molecule.

The DNA molecules according to the invention contain regions in the coding region which are capable of specifically directing the protein synthesized in the cytoplasm on the ribosomes to plastids and to prevent occurrence of the protein in other membrane systems of the cell. The protein region which directs the protein coded for by the DNA
molecules according to the invention to the plastids is located within the first hundred amino acids of the protein, is not required for the transport function of the protein and is removed after successful insertion of the protein in the chloroplast envelope membrane. By exchanging this plastid targeting sequence with one of the known targeting sequences for, e.g., mitochondria, the translocator protein could be directed to another membrane system of eucaryotic cells and could there possibly modify the transport properties across the respective membrane. Likewise, the plastid targeting sequence of the 2-oxoglutarate/malate translocator, particularly the first 100 amino acids, or endogenous regions of the mature protein could be used to direct foreign proteins (e.g., proteins catalyzing the active or passive transport of metabolites across membranes, enzymes, bacterial transport proteins or transporters from yeasts) to the plastids, particularly the plastid envelope membrane, to the plastid stroma or to the thylakoids of plant cells.

On June 9, 1994 the following plasmids were deposited in the E. coli strains indicated with the recognized international depository Deutsche Sammlung von Mikroorganismen (DSM) [German collection of microorganisms] in Brunswick, Federal Republic of Germany, in accordance with the stipulations of the Budapest Treaty:

Plasmid pBinAR-211 (DSM 9239) Plasmid pEVP11-211 (DSM 9237) Plasmid pBSC-211 (DSM 9238) Description of the Figures:

Figure 1: Reconstitution of the transport activity of the recombinant 2-oxoglutarate/malate translocator expressed in yeast The Figure shows the uptake of [14C] malate in reconstituted liposomes containing S. pombe cell membranes.
Figure 2: Schematic view of the cloning of plasmid pEVP11-211 (Figure 2A) and of plasmid pBinAR-211 (Figure 2B) Figure 3: Targeting of the 2-oxoglutarate/malate translocator precursor protein to the chloroplasts and energy-dependent insertion of the mature protein in the inner envelope membrane SDS polyacrylamide gel electrophoresis was carried out as described in Example 6:

Lane 1: in vitro translated precursor protein Lanes 2-4: - dark conditions Lanes 5-9: light conditions Lane 2: without ATP
Lane 3: plus 2 mM ATP
Lane 4: plus 2 mM ATP, subsequent treatment with protease (100 g/ml) Lane 5: without ATP
Lane 6: plus 2 mM ATP
Lane 7: plus 2 mM ATP, subsequent treatment with protease (100 g/ml) Lane 8: plus decoupling agent (10 M CCCP) Lane 9: plus 2 mM ATP; protease-pretreated chloro-plasts (30 g/ml) For a better understanding of the examples underlying the present invention, some of the methods used are explained in more detail in the following.

1. Cloning methods For cloning phage lambda gt10 as well as the vector pBluescript II KS (pBSC) (Short et al., 1988, Nucl. Acids Res. 16:7583-7600) were used.

18 ? j JL8't I
For the transformation of yeasts vector pEVPll (Russel and Nurse, 1986, Cell 45:145-153) was used.

For plant transformation the gene constructs were cloned into the binary vector pBinAR (Hofgen and Willmitzer, 1990, Plant Sci. 66:221-230).

2. Bacteria and yeast strains For the pBluescriptKS (pBSC) vector as well as for the pEVPll and-pBinAR constructs E. coli strains DHSa (Hanahan et al., 1983, J. Mol. Biol. 166:557-580) and TG1 (Gibson, 1984, Ph.D. Thesis, Cambridge University, England) were used.

Transformation of the pBinAR constructs in tobacco plants was carried out with the Agrobacterium tumefaciens strain LBA4404 (Bevan, 1984, Nucl. Acids Res. 12:8711:8720).

3. Transformation of Agrobacterium tumefaciens The transfer of the DNA into the Agrobacteria was brought about by the direct transformation according to the method by Hdfgen and Willmitzer (1988, Nucl. Acids Res. 16:9877).
The plasmid DNA of transformed Agrobacteria was isolated according to the method by Birnboim and Doly (1979, Nucl.
Acids Res. 7:1513-1523) and analyzed by gel electrophoresis for correctness and orientation after suitable restriction digestion.

4. Plant transformation Per transformation 15 small leaves of a tobacco sterile culture which were wounded with sanding paper and a scalpel were placed in 10 ml MS medium containing 2% sucrose which contained 100 l of a strictly selectively grown, transformed overnight culture of Agrobacterium tumefaciens.

2 19284?

After gently shaking the mixture for 15 minutes the leaves were placed on MS medium containing 1.6% glucose, 2 mg/l zeatin ribose, 0.02 mg/1 naphthyl acetic acid, 0.02 mg giberellic acid, 500 mg/1 Betabactyl , 15 mg/l hygromycin and 0.8% Bacto agar. After incubation at 25 C and 3,000 lux light intensity for one week, the Betabactyl concentration in the medium was reduced by half.

The examples illustrate the invention.
- Example 1 Isolation of peptide fragments of the 2-oxoglutarate/malate translocator and preparation of probes for the hybridization screening of cDNA libraries Purified 2-oxoglutarate/malate translocator protein (Menzlaff and Fli.igge, 1993, Biochim. Biophys. Acta 1147:13-18) was separated from remaining impurities in preparative SDS polyacrylamide gels (Laemmli, 1970, Nature 227:680-685) and cut out from the gel after detection of the protein by copper(II) sulfate staining (Lee et al., 1987, Anal.
Biochem. 166:308-312) and digested in the gel matrix with endoproteinase LysC (Eckerskorn and Lottspeich, 1989, Chromatographia 28:92-94). The resulting peptides were eluted from the gel and separated via HPLC. The amino acid sequence of the purified peptide fractions was determined in the gaseous phase by automated Edman degradation (Eckerskorn et al., 1988, Eur. J. Biochem. 176:509-519). Degenerate oligonucleotide sequences coding for these amino acids were derived from the amino acid of three peptides and the respective oligonucleotides were prepared by in vitro DNA
synthesis. For use as probe the oligonucleotides were radioactively labelled by affixing a 32P phosphate group to the 5' end via an oligonucleotide kinase.

20 ~ 4~
Example 2 Cloning of the 2-osoglutarate/malate translocator from spinach From young leaves of spinach plants grown in hydroculture poly-A+ RNA was isolated and on this basis a cDNA library was constructed in vector lambda gt10 (FlUgge et al., 1989, EMBO J. 8: 39-46) . About 300,000 clones of this library were screened with synthetic oligonucleotides which were modelled after endoproteinase LysC peptide fragments of the purified 2-oxoglutar-ate/malate translocator (see Example 1).
Positively reacting clones were purified by standard techniques and after preparation of the amplified phage DNA
from the purified plaques the insert coding for the 2-oxoglutarate/malate translocator was obtained by EcoRI
restriction digestion and verified by Southern blot analyses using the above-mentioned oligonucleotides as probe. After recloning of the inserts of the phage DNA into the vector pBluescript (pBSC) the clones were analyzed by determining the DNA sequence (didesoxy method: Sanger et al., 1977, Proc. Natl. Acad. Sci. USA 74:5463-5467) and from this DNA
sequence the primary structure of the 2-oxoglutarate/malate translocator was derived. The sequence of the oligonucleotides or peptides used for screening the cDNA
library could be recovered.

Example 3 Expression of the 2-oxoglutarate/malate translocator from spinach in the fission yeast Schizosaccharomyces pombe The above-mentioned plasmid pBluescript (pBSC) containing the insert coding for the 2-oxoglutarate/malate translocator was linearized with the endonuclease SalI and the resulting cohesive ends were filled in with the enzyme T4-DNA
polymerase. Then the insert was cut out from the vector by another restriction digestion with BamHI and isolated by electrophoresis. The fragment obtained in this manner was inserted in a specific orientation into the yeast expression vector pEVP11, which was first linearized with SacI, the ends filled up with T4-DNA polymerase and then digested again with BamHI (see also Figure 2A) and, after amplification of the construct in E. coli, transformed in leucine synthesis deficient S. pombe cells which had been made competent by LiCl/PEG (Ito et al., 1983, J. Bact.
153:163-168). Transformants were selected without leucine by selection on minimum essential medium, since the pEVP11-211 construct imparts to the yeast cells the capability for growth on leucine-free medium.

Example 4 Measurement of the malate transport activity in recombinant yeast lines Yeast cells transformed with pEVP11-211 plasmid (see Figure 2A, SP-DC3 cells) were grown in minimum essential medium up to an optical density of 1.0 at 600 nm and harvested by centrifugation at 3,000 x g for 5 minutes. The cells were disrupted by vigorously shaking the mixture with 1/2 vol.
(based on the cells) glass beads and glass beads and cell debris were separated by centrifugation (600 g for 1 minute). The supernatant was adjusted to a concentration of 0.5% (weight/volume) Triton X-100, an equal volume of liposomes was added to the mixture and the resulting proteoliposomes were immediately frozen in liquid nitrogen.
The liposomes were previously prepared by sonification of soy bean phospholipid (20 mg/ml for 10 minutes at 4 C in the presence of 200 mM tricine NaOH (pH 7.6), 40 mM malate and 60 mM potassium gluconate. After thawing of the proteoliposomes and sonification of the suspension with 10 pulses cA 1 s the proteoliposomes were separated from the surround~ing medium by size exclusion chromatography on Sephadex G-25 which had been equilibrated with 10 mM tricine NaOH (pH 7.6), 100 mM sodium gluconate and 50 mM potassium gluconate. The eluted proteoliposomes were used for 22 L' I 9?849 measuring malate transport activity. The measurement was carried out according to the "inhibitor stop" method described by Menzlaff and Fliigge (1993, Biochim. Biophys.
Acta 1147:13-18).
The malate transport activity in the pEVP11-211 transformants was compared with the malate transport activity of transformants that were merely transformed with the vector pEVPll without the 211 insert. It was found that the malate transport activity in the pEVP11-211 transformants (measured in pmol of transported 14C malate/mg protein * -hour) was 100-fold higher than in the pEVPll control transformants. (Figure 1). It furthermore could be demonstrated that the recombinant translocator protein exhibits identical transport characteristics as compared with the authentic protein of the chloroplast membrane. This finding is shown in the following table.

19284~

~4 O ~ b N Cn +J E-4 4J 'd -r-I N
* U 4 O -.,OI O = -1 >
Gl p M a U
tu ,O R3 ~

a1 ~' ~ +J >4 O ~ 4J
-r~ 4J r-1 w 10 z d' Nr-I '-4 }J fV Q $4 b 0 f14 04.1 U

Q,, o 4, s~~ ~or-, rl tT iT y 0) W W y O :0 a Op O--1 fj, E
N >4 i, +J . H
tv 04 4-) N N
y A ~ -> oi Q ~. N N rl N rl rq r-i =' 41 W U U
e-4 r-I p O +i +I +1 +I +I +I +I 41 44 a ~. v v v v v v .~ rl r{
'3 A OD
~ ~ V ~ N d' N ~0 N
~ ~ 0 W
m t~ l~ ln st' rl ~i N O 0 q ~~ o O O o~ f1~ " ~
r1 = r > rq 4' a 4, 0 a A
O U
V A ~
N u~ =~' a o u (d 4J 3 U 4) -H W 4J
i0 -H C,) 0 ca ~4 0) 4J o ..
~ ~ i 0 0 W Oco cp m +1 ~ tn ~ .-. .-. .~ G) -~ N ='~ . C
"I s3~ .-.s .. N N d' d' , .. .. ~+ .~' f~ 0 ~ ~ N I o+I ri r-I e- +1 rl O ~
'Q ~ 0 ri'= v +I +I +I +I +I d O b f 0 .. .~ ~. .. .. A N O +J 0 ~ ~ c0 =~ w COi'=. rq r~ r~ sr T-1 ch 7-4 W U c~C 3,~ ~
ao ~o qv ~ ~ Q N Q Q => ~ =rl V
m o b Q, O~=,I a~ a~ o 0 .,, ~ , a ~s ~ o ~4 ~4 -,4 04 O o 3 ~ ~ rn O -~I rd b o 0 ~ '=.~

-r1 ri ~
0+ CO
~~ N
U
d N 4J H p r 0 m - ro o 0 > ~ =~+ N W
4-) -N w ~ r, E b ~
N U e-I O N
m à ~4 A +J (o ~ = a+~ ~
Ul 0 Gl 4J 0 N N MI 0 U41 N 'C3 z a a) ~ ro ro ~ ro ro +~ (1) ~ o ~ ~ ~ -~ .a ry o a) ar. k tr +1 ao O. o~ W
G) 41 E O k =rl f0 O 54 td o GI U1 Ul ri =ri ~
r1 7 1 O (C ( 0 U i~ h Cd ~~' r-1 Gl f. c" 1 O O-I ed ar-I 0 U a o 04 :1 +) o p 0 rn a~ o Q
~ =r-4 a a or-i I v, r-I =H .c (1) k rn-H a N m :a~r~cnc~Nac~3 a+~rlr-l~-~- 49 Example 5 Transformation of plants with a construct for the over-expression of the coding region of the 2-oxoglutarate/malate translocator From vector pBluescript-211 (pBSC-211) which contained as insert the cDNA for the 2-oxoglutarate/malate translocator from spinach (see Example 2, Figure 2B) the insert was isolated by restriction digestion with EcoRV and SmaI and cloned into vector pBinAR (Hofgen and Willmitzer, 1990, Plant Sci.-66:221-230) which was digested with the enzyme SrnaI. After amplification of the resulting construct pBinAR-211 in E. coli the construct was transformed in agrobacteria and the latter were used to infect leave segments of tobacco and potato.
The resulting transformants were screened in Southern blot analyses for the presence of the intact, not rearranged chimeric gene. Using the "whole leave reconstitution method"
(FlUgge et Weber, 1994, Planta, 194:181-185) the malate transport activity was examined as compared to that of control transformants (transformed with vector pBinAR
without insert), as well as the C/N ratio, photosynthesis rate, transpiration and growth.

Example 6 Targeting of the 2-oxoglutarate/malate translocator precursor protein to the chloroplasts and energy-dependent insertion of the mature protein into the inner envelope membrane The in vitro transcription of plasmid pBSC-211 which was linearized with SmaI was carried out using T3 RNA polymerase according to the instructions of the manufacturer (Pharmacia). Subsequent in vitro translation was carried out in the reticulocyte lysate (Boehringer-Mannheim). The post-ribosomal supernatant was used for protein transports in intact spinach chloroplasts. The experiment was carried out in the dark as well as in the light; the preparation contained import buffer (FlUgge et al., 1989, EMBO J. 8:39-46), intact spinach chloroplasts (corresponding to 200 mg chlorophyll) and various additives indicated in the legend to Figure 3 (entire volume: 300 ml). After 15 minutes at 25 C the chloroplasts were washed and the envelope membranes were isolated (FlUgge et al., 1989, EMBO J. 8:39-46) were isolated. They were analyzed in a SDS polyacrylamide gel electrophoresis (Laemmli, 1970, Nature 227:680-685) and subsequent fluorography (Bonner and Laskey, 1974, Eur. J.
Biochem. 46:84-88) (Figure 3). Lane 1 shows the in vitro translated precursor protein (p). Lanes 2-4: dark conditions, lanes 5-9: light conditions. Under all conditions the presequence of the 2-oxoglutarate/malate translocator directs the affixed mature protein correctly to its target membrane, the inner envelope membrane of the chloroplasts; it is cleaved during the import process by a specific protease; the mature protein (m) is formed. In the dark the insertion of the translocator is provided with energy by adding ATP (lanes 3 and 4). In the absence of ATP
(lane 1) no import is observed. In the light the energy for the import of the protein can be provided in the form of ATP
via photosynthetic phosphorylation; the import under these conditions is independent of exogenous ATP (lane 5) but can be increased by ATP added from the exterior (lane 6). If photosynthetic phosphorylation and the resulting production of ATP is prevented by adding a decoupling agent such as CCCP, the protein import is blocked (lane 8). The mature protein is present incorporated in the inner membrane:
addition of proteases (e.g., thermolysine), which cannot permeate the outer envelope membrane are not capable of affecting the mature protein incorporated in the inner membrane (lanes 4 and 7). A pretreatment of the chloroplasts with a protease (e.g., thermolysine) leads to the complete loss of the binding and of the import of the translocator (lane 9). This goes to show that the presequence (targeting sequence) of the translocator in a first step needs to be ? 1 q2 849 specifically bound to receptors located on the outer membrane. Only then the further steps of protein-insertion can be taken.

' ~
27 'ryq SEQUENCE LISTING

(1) GENERAL INFORMATION:
(i) APPLICANT:
(A) NAME: Institut fuer Genbiologische Forschung Berlin GmbH
(B) STREET: Ihnestr. 63 (C) CITY: Berlin (E) COUNTRY: DE
(F) POSTAL CODE (ZIP): 14195 (G) TELEPHONE: (030) 83 00 07-0 (H) TELEFAX: (030) 83 00 07-36 (ii) TITLE OF INVENTION: DNA molecules which code for a plastid 2-oxoglutarate/malate translocator (iii) NIIMBER_OF SEQUENCES: 2 (iv) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: PatentIn Release #1.0, Version #1.30 (EPO) (vi) PRIOR APPLICATION DATA:
(A) APPLICATION NUMBER: DE P 44 20 782.4 (B) FILING DATE: 15-JUN-1994 (2) INFORMATION FOR SEQ ID NO: 1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1945 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA

(vi) ORIGINAL SOURCE:
(A) ORGANISM: Spinacia oleracea (vii) IMMEDIATE SOURCE:
(A) LIBRARY: cDNA library in phage lambda gt10 (ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION:14..1720 (D) OTHER INFORMATION:/note=
"2-Oxoglutarate/malate-translocator"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:

Met Ala Ser Met Ala Leu Ser Leu Thr Ser Ser Pro 28 L ~f .1 L 80 Thr Tyr Ser Leu Ser Phe Arg Ser Leu Pro Ser Leu Lys Pro Leu Ser Lys Ser Gln Pro Ser Ile Ser Leu Pro Ser Leu Arg Ser Asn Ala Ser Lys Ser Pro Ser Leu Ser His Lys His Phe Leu Ser Pro Pro Ser Leu Leu Leu Pro His Lys Leu Lys Pro Ile Ser Ala Ser Ser Pro Thr Asn Pro Pro Pro Pro -Pro Ala Pro Val Pro Ser Pro Ala Pro Val Ser Ala Pro Ala Gln Val Gln Pro Trp Gln Gly Ala Ser Ile Lys Pro Leu Leu Ala Ser Ile Leu Thr Gly Val Ile Ile Trp Phe Ile Pro Thr Pro Glu Gly Val Ser Arg Asn Ala Trp Gln Leu Leu Ala Ile Phe Leu Ser Thr Ile Val Gly Ile Ile Thr Gln Pro Leu Pro Leu Gly Ala Val Ala Leu Met Gly Leu Gly Ala Ser Val Leu Thr Lys Thr Leu Thr Phe Ser Ala Ala Phe Ser Ala Phe Gly Asp Pro Ile Pro Trp Leu Ile Ala Leu Ala Phe Phe Phe Ala Arg Gly Phe Ile Lys Thr Gly Leu Gly Asn Arg Ile Ala Tyr Gln Phe Val Lys Leu Phe Gly Ser Ser Ser Leu Gly Leu Gly Tyr Ser Leu Val Phe Ser Glu Ala Leu Leu Ala Pro Ala Ile Pro Ser 29 '1q284?

Val Ser Ala Arg Ala Gly Gly Ile Phe Leu Pro Leu Val Lys Ser Leu Cys Ile Ala Cys Gly Ser Asn Val Gly Asp Gly Thr Glu Arg Lys Leu Gly Ala Trp Leu Met Leu Thr Cys Phe Gln Thr Ser Val Ile Ser Ser Ser Met Phe Leu Thr Ala Met Ala Ala Asn Pro Leu Ser Ala Thr Leu Thr Phe Asn Thr Ile Gly Lys Ala Ile Gly Trp Met Asp Trp Ala Lys Ala Ala Phe Val Pro Gly Leu Val Ser Leu Ile Val Val Pro Leu Leu Leu Tyr Val Val Tyr Pro Pro Glu Ile Lys Ser Ser Pro Asp Ala Pro Arg Leu Ala Lys Glu Lys Leu Asp Lys Met Gly Pro Met Thr Lys Asn Glu Ser Ile Met Ala Val Thr Leu Leu Leu Thr Val Gly Leu Trp Val Phe Gly Gly Lys Leu Gly Val Asp Ala Val Thr Ala Ala Ile Leu Gly Leu Ser Val Leu Leu Ile Thr Gly Val Val Thr Trp Lys Glu Cys Leu Ala Glu Ser Val Ala Trp Asp Thr Leu Thr Trp Phe Ala Ala Leu Ile Ala Met Ala Gly Tyr Leu Asn Lys Tyr Gly Leu Ile Thr Trp Phe Ser Glu Asn Val Val Lys Val Val Gly Gly Leu Gly Leu Ser Trp Gln Met Ser Phe Gly Val Leu Val Leu Leu Tyr Phe Tyr Ser His Tyr Phe Phe Ala Ser Gly Ala Ala His Ile Gly Ala Met Phe Thr Ala Phe Leu Ser Val Ala Ser Ala Leu Gly Thr Pro Pro Phe Leu Ala Ala Ile Val Leu Ser Phe Leu Ser Asn Leu Met Gly Gly Leu Thr His Tyr Gly Ile Gly Ser Ala Pro Val Phe Tyr Gly Ala Asn Tyr Val Pro Leu Pro Gln Trp Trp Gly Tyr Gly -Phe Leu Ile Ser Ile Val Asn Leu Ile Ile Trp Leu Gly Val Gly Gly Leu Trp Trp Lys Ala Ile Gly Leu Trp (2) INFORMATION FOR SEQ ID NO: 2:

(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 569 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:

Met Ala Ser Met Ala Leu Ser Leu Thr Ser Ser Pro Thr Tyr Ser Leu Ser Phe Arg Ser Leu Pro Ser Leu Lys Pro Leu Ser Lys Ser Gln Pro Ser Ile Ser Leu Pro Ser Leu Arg Ser Asn Ala Ser Lys Ser Pro Ser Leu Ser His Lys His Phe Leu Ser Pro Pro Ser Leu Leu Leu Pro His Lys Leu Lys Pro Ile Ser Ala Ser Ser Pro Thr Asn Pro Pro Pro Pro 31 ~19204f Pro Ala Pro Val Pro Ser Pro Ala Pro Val Ser Ala Pro Ala Gln Val Gln Pro Trp Gln Gly Ala Ser Ile Lys Pro Leu Leu Ala Ser Ile Leu Thr Gly Val Ile Ile Trp Phe Ile Pro Thr Pro Glu Gly Val Ser Arg Asn Ala Trp Gln Leu Leu Ala Ile Phe Leu Ser Thr Ile Val Gly Ile Ile Thr Gln Pro Leu Pro Leu Gly Ala Val Ala Leu Met Gly Leu Gly Ala Ser Val Leu Thr Lys Thr Leu Thr Phe Ser Ala Ala Phe Ser Ala Phe Gly Asp Pro-Ile Pro Trp Leu Ile Ala Leu Ala Phe Phe Phe Ala Arg Gly Phe Ile Lys Thr Gly Leu Gly Asn Arg Ile Ala Tyr Gln Phe Val Lys Leu Phe Gly Ser Ser Ser Leu Gly Leu Gly Tyr Ser Leu Val Phe Ser Glu Ala Leu Leu Ala Pro Ala Ile Pro Ser Val Ser Ala Arg Ala Gly Gly Ile Phe Leu Pro Leu Val Lys Ser Leu Cys Ile Ala Cys Gly Ser Asn Val Gly Asp Gly Thr Glu Arg Lys Leu Gly Ala Trp Leu Met Leu Thr Cys Phe Gln Thr Ser Val Ile Ser Ser Ser Met Phe Leu Thr Ala Met Ala Ala Asn Pro Leu Ser Ala Thr Leu Thr Phe Asn Thr Ile Gly Lys Ala Ile Gly Trp Met Asp Trp Ala Lys Ala Ala Phe Val Pro Gly Leu Val Ser Leu Ile Val Val Pro Leu Leu Leu Tyr Val Val Tyr Pro Pro Glu Ile Lys Ser Ser Pro Asp Ala Pro Arg Leu Ala Lys Glu Lys Leu Asp Lys Met Gly Pro Met Thr Lys Asn Glu Ser Ile Met Ala Val Thr Leu Leu Leu Thr Val Gly Leu Trp Val Phe Gly Gly Lys Leu Gly Val Asp Ala Val Thr Ala Ala Ile Leu Gly Leu Ser Val Leu ?19284q Leu Ile Thr Gly Val Val Thr Trp Lys Glu Cys Leu Ala Glu Ser Val Ala Trp Asp Thr Leu Thr Trp Phe Ala Ala Leu Ile Ala Met Ala Gly Tyr Leu Asn Lys Tyr Gly Leu Ile Thr Trp Phe Ser Glu Asn Val Val Lys Val Val Gly Gly Leu Gly Leu Ser Trp Gln Met Ser Phe Gly Val Leu Val Leu Leu Tyr Phe Tyr Ser His Tyr Phe Phe Ala Ser Gly Ala Ala His Ile Gly Ala Met Phe Thr Ala Phe Leu Ser Val Ala Ser Ala Leu Gly Thr Pro Pro Phe Leu Ala Ala Ile Val Leu Ser Phe Leu Ser Asn Leu Met Gly Gly Leu Thr His Tyr Gly Ile Gly Ser Ala Pro Val Phe Tyr Gly Ala Asn Tyr Val Pro Leu Pro Gln Trp Trp Gly Tyr Gly Phe Leu Ile Ser Ile Val Asn Leu Ile Ile Trp Leu Gly Val Gly Gly Leu Trp Trp Lys Ala Ile Gly Leu Trp

Claims (15)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE PROPERTY
OR PRIVELEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. An isolated DNA molecule coding for a plastid 2-oxoglutarate/malate translocator selected from the group consisting of (a) DNA molecules coding for a protein having the amino acid sequence shown in SEQ
ID No. 2;

(b) DNA molecules comprising SEQ ID No. 1;

(c) DNA molecules that hybridize with the complementary strand of the DNA
molecule mentioned in (a) or (b) under stringent hybridization conditions, wherein the hybridizing DNA molecule encodes a naturally-occurring protein having plastid oxoglutarate/malate translocator activity;

(d) DNA molecules the sequence of which is degenerate as a result of the genetic code compared to the sequences of the DNA molecules mentioned in (c); and (e) DNA molecules that are fully complementary to the molecules mentioned in (a), (b), (c) or (d).
2. An isolated recombinant DNA molecule containing a DNA molecule according to claim 1.
3. The recombinant DNA molecule according to claim 2, wherein the DNA molecule according to claim 1 is linked with DNA sequences ensuring transcription in procaryotic or eukaryotic cells.
4. The recombinant DNA molecule according to claim 3, wherein said molecule as defined in claim 1 is selected from (a), (b), (c) or (d), which ensures expression of a translatable mRNA
coding for a protein having the activity of a 2-oxoglutarate/malate translocator.
5. Plasmid pBSC-211, deposited as DSM 9238 in E. coli strain TG1 pBSC-211.
6. Plasmid pEVP11-211, deposited as DSM 9237 in E. coli strain TG1 pEVP11-211.
7. Plasmid-pBinAR-211, deposited as DSM 9239 in E. coli strain TG1 pBinAR-211.
8. A host bacterium, containing a DNA molecule according to claim 1, a recombinant DNA
molecule according to any one of claims 2 to 4, or a plasmid according to any one of claims 5 to 7.
9. A transgenic fungal cell containing a DNA molecule according to claim 1, a recombinant DNA molecule according to any one of claims 2 to 4, or a plasmid according to any one of claims 5 or 6.
10. An isolated protein having the activity of a plastid 2-oxoglutarate/malate translocator coded for by a DNA molecule as defined in (a), (b), (c), or (d) of claim 1.
11. Use of a polypeptide comprising part or all of the first 100 amino acids of the protein as encoded by the DNA molecule as defined in (a), (b), (c) or (d) of claim 1, for targeting a procaryotic or eukaryotic protein coupled thereto into the plastid envelope membrane, into the plastid stroma or into the thylakoids.
12. Transgenic plant cells containing a recombinant molecule as defined in any one of claims 2 to 4, or a plasmid as defined in claims 5, 6 or 7.
13. Use of a DNA molecule as defined in claim 1 for the isolation of DNA
molecules coding for a polypeptide having the biological activity of a dicarboxylate translocator.
14. The use of claim 13, wherein the dicarboxylate translocator is a 2-oxoglutarate/malate translocator.
15. Use of a DNA molecule as defined in (a), (b), (c) or (d) of claim 1, or a part thereof, wherein the part contains a coding region coding for a mature protein having the biological activity of a 2-oxoglutarate/malate translocator, for combination with targeting sequences for other cell compartments or cellular membrane systems, whereby the mature protein is directed into other compartments or membrane systems.
CA002192849A 1994-06-15 1995-06-14 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator Expired - Fee Related CA2192849C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4420782.4 1994-06-15
DE4420782A DE4420782C1 (en) 1994-06-15 1994-06-15 New DNA encoding a 2-oxoglutarate-malate translocator
PCT/EP1995/002319 WO1995034654A1 (en) 1994-06-15 1995-06-14 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator

Publications (2)

Publication Number Publication Date
CA2192849A1 CA2192849A1 (en) 1995-12-21
CA2192849C true CA2192849C (en) 2008-11-04

Family

ID=6520570

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002192849A Expired - Fee Related CA2192849C (en) 1994-06-15 1995-06-14 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator

Country Status (11)

Country Link
US (2) US5981219A (en)
EP (1) EP0765393B1 (en)
JP (1) JPH09512178A (en)
KR (1) KR970704038A (en)
AT (1) ATE255636T1 (en)
AU (1) AU708654B2 (en)
CA (1) CA2192849C (en)
DE (2) DE4420782C1 (en)
HU (1) HU221178B1 (en)
RU (1) RU2188866C2 (en)
WO (1) WO1995034654A1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517674D0 (en) * 1995-08-30 1995-11-01 Lynxvale Ltd Plastid inner envelope membrane targeting polypeptides;manufacture and use thereof
DE19600357C1 (en) * 1996-01-08 1997-02-13 Fluegge Ulf Ingo Prof Dr DNA sequence encoding a phosphoenolpyruvate phosphate translocator, plasmids, bacteria, yeasts and plants containing this transporter
GB2331753A (en) * 1996-11-01 1999-06-02 Inst Medical W & E Hall Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
EP0972780A1 (en) * 1998-05-18 2000-01-19 Applied Research Systems ARS Holding N.V. Il-6 antagonist peptides
DE19853778C1 (en) * 1998-11-21 2000-09-21 Basf Ag DNA sequences encoding a glutamate / malate translocator, plasmid bacteria, yeast and plants containing this transporter
DE10036671A1 (en) * 2000-07-27 2002-02-21 Frommer Wolf Bernd New nucleic acid encoding mitochondrial transporter, useful for preparing transgenic plants with e.g. altered protein content and improved germination
US6416982B1 (en) 2000-09-05 2002-07-09 Ultra Biotech Ltd. Biological fertilizer based on yeasts
WO2002020431A1 (en) 2000-09-05 2002-03-14 Ultra Biotech Limited A biological fertilizer based on yeasts
EP1363865A2 (en) * 2001-03-01 2003-11-26 Ultra Biotech Limited Biological fertilizer compositions comprising manure, sludge or garbage
US20020123130A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for degrading polymeric compounds
US20020123129A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for degrading nitrogen-containing compounds
US6800466B2 (en) 2001-03-01 2004-10-05 Ultra Biotech Limited Biological fertilizer compositions comprising sludge
US6596272B2 (en) * 2001-03-01 2003-07-22 Ultra Biotech Limited Biological fertilizer compositions comprising poultry manure
US6596273B2 (en) * 2001-03-01 2003-07-22 Ultra Biotech Limited Biological fertilizer compositions comprising swine manure
US6828132B2 (en) * 2001-03-01 2004-12-07 Ultra Biotech Limited Biological fertilizer compositions comprising garbage
US6761886B2 (en) 2001-03-01 2004-07-13 Ultra Biotech Limited Biological fertilizer compositions comprising cattle manure
US20020123127A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for reducing odor
DE10163167A1 (en) * 2001-12-21 2003-07-03 Degussa Process for the fermentative production of L-amino acids and use of coryneform bacteria
US20040005336A1 (en) * 2002-06-28 2004-01-08 Cheung Ling Yuk Dietary supplements for regulating the central nervous system
US20040001859A1 (en) * 2002-06-28 2004-01-01 Cheung Ling Yuk Anti-aging dietary supplements
US20040001857A1 (en) * 2002-06-28 2004-01-01 Cheung Ling Yuk Dietary supplements for treating hypertension
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) * 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) * 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6987012B2 (en) * 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US7204987B2 (en) * 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7214377B2 (en) * 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984507B2 (en) * 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US7226600B2 (en) * 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6989253B2 (en) * 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) * 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) * 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US20040265990A1 (en) * 2003-06-30 2004-12-30 Cheung Ling Yuk Biological compositions for reduction of E. coli infections
US7297522B2 (en) * 2003-11-18 2007-11-20 Ultra Biotech Limited Methods and compositions for treating epilepsy
US7259001B2 (en) * 2003-11-18 2007-08-21 Ultra Biotech Limited Methods and compositions for treating male sexual dysfunction
US6913913B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating renal failure
US6979562B2 (en) * 2003-11-18 2005-12-27 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US6913914B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating hepatitis B
US7078202B2 (en) * 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
US6964864B2 (en) * 2003-11-18 2005-11-15 Ultra Biotech Limited Methods and compositions for treating gastritis
US6977168B2 (en) 2003-11-18 2005-12-20 Ultra Biotech Limited Methods and compositions for treating nephrotic syndrome
US20050106166A1 (en) * 2003-11-18 2005-05-19 Cheung Ling Y. Methods and compositions for treating liver cirrhosis
US20050106705A1 (en) * 2003-11-18 2005-05-19 Cheung Ling Y. Methods and compositions for treating hyperlipemia
US7082844B1 (en) 2005-02-16 2006-08-01 Cts Corporation Strain sensor having improved accuracy
US7441467B2 (en) * 2006-07-12 2008-10-28 Cts Corporation Compression strain sensor
CA2788238C (en) * 2010-02-04 2019-09-03 Fritz Kreuzaler A method for increasing photosynthetic carbon fixation using glycolate dehydrogenase multi-subunit fusion protein
AU2018290308B2 (en) * 2017-06-23 2022-03-03 Yield10 Bioscience, Inc. Methods and genes for producing land plants with increased expression of mitochondrial metabolite transporter and/or plastidial dicarboxylate transporter genes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306708C (en) * 1986-07-28 1992-08-25 National Development Corporation Limited (The) Dicarboxylic acid transport genes
US5866777A (en) * 1991-11-20 1999-02-02 Mogen International, N.V. Method for obtaining plants with reduced susceptibility to plant-parasitic nematodes
DE4220759A1 (en) * 1992-06-24 1994-01-05 Inst Genbiologische Forschung DNA sequences for oligosaccharide transporters, plasmids, bacteria and plants containing a transporter as well as methods for the production and transformation of yeast strains to identify the transporter
DE4222315A1 (en) * 1992-07-05 1994-01-13 Inst Genbiologische Forschung DNA sequences for amino acid transporters, plasmids, bacteria, yeasts and plants containing a transporter
WO1994010320A1 (en) * 1992-11-02 1994-05-11 Mogen International N.V. Plants with reduced susceptibility to plant-parasitic nematodes

Also Published As

Publication number Publication date
DE59510842D1 (en) 2004-01-15
JPH09512178A (en) 1997-12-09
KR970704038A (en) 1997-08-09
US5981219A (en) 1999-11-09
HU9603441D0 (en) 1997-02-28
AU708654B2 (en) 1999-08-12
HU221178B1 (en) 2002-08-28
CA2192849A1 (en) 1995-12-21
EP0765393B1 (en) 2003-12-03
EP0765393A1 (en) 1997-04-02
US6225526B1 (en) 2001-05-01
WO1995034654A1 (en) 1995-12-21
HUT76090A (en) 1997-06-30
ATE255636T1 (en) 2003-12-15
AU2792495A (en) 1996-01-05
DE4420782C1 (en) 1995-08-17
RU2188866C2 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
CA2192849C (en) Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
ES2204903T3 (en) DNA SEQUENCES CODING A CARRIER OF OLIGOSACARIDS.
CA2919813C (en) Gene capable of increasing seed protein content and method of use thereof
US6825335B1 (en) Synthetic fatty acid desaturase gene for expression in plants
AU715382B2 (en) Process and DNA molecules for increasing the photosynthesis rate in plants
CA2236267A1 (en) Plant vde genes and methods related thereto
EP0652955B1 (en) Dna sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use
AU694457B2 (en) DNA sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter
AU1961699A (en) Modification of the tocopherol content of transgenic plants
CA2204023A1 (en) Processes for modifying plant flowering behaviour
JP2003511049A (en) Method for increasing crop yield or biomass using protoporphyrinogen oxidase gene
MXPA97009724A (en) Fiber transcription factors of something

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed